Viatris (VTRS) Exchange Rate Effect (2019 - 2026)
Viatris (VTRS) posted quarterly Exchange Rate Effect of -$4.2 million for Q1 2026, down 125.0% year-over-year from $16.8 million in Q1 2025, and up 82.28% quarter-over-quarter from -$23.7 million in Q4 2025.
Viatris (VTRS) Exchange Rate Effect (2019 - 2026) Analysis & Trends
Viatris' Exchange Rate Effect history runs 8 years deep, the most recent figure standing at -$4.2 million for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 125.0% year-over-year to -$4.2 million; the TTM figure through Mar 2026 stood at -$3.4 million (down 126.67% YoY), while the FY2025 annual figure was $17.6 million, up 157.33% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$4.2 million, up from -$23.7 million in the prior quarter.
- The five-year high for Exchange Rate Effect was $23.9 million in Q3 2024, with the low at -$37.8 million in Q4 2024.
- The 5-year median for Exchange Rate Effect is -$4.2 million (2026), against an average of -$3.5 million.
- Peak annual rise in Exchange Rate Effect reached 1139.13% in 2024, while the deepest fall reached 1133.33% in 2024.
- Viatris' Exchange Rate Effect stood at $15.6 million in 2022, then fell by 18.59% to $12.7 million in 2023, then sank by 397.64% to -$37.8 million in 2024, then jumped by 37.3% to -$23.7 million in 2025, then soared by 82.28% to -$4.2 million in 2026.
- Business Quant data shows VTRS's Exchange Rate Effect at -$4.2 million in Q1 2026, -$23.7 million in Q4 2025, and $17.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -5.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | -7.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 39.87 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -3.30 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 9.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alkermes | 8.15 Bn | 7.49 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.30 Mn |
| Jun 30, 2026 | -3.30 Mn |
| Mar 31, 2026 | -4.20 Mn |
| Mar 31, 2026 | -4.20 Mn |
| Dec 31, 2025 | -23.70 Mn |
| Dec 31, 2025 | -23.70 Mn |
| Sep 30, 2025 | 17.80 Mn |
| Sep 30, 2025 | 17.80 Mn |
| Jun 30, 2025 | 6.70 Mn |
| Jun 30, 2025 | 6.70 Mn |
| Mar 31, 2025 | 16.80 Mn |
| Mar 31, 2025 | 16.80 Mn |
| Dec 31, 2024 | -37.80 Mn |
| Dec 31, 2024 | -37.80 Mn |
| Sep 30, 2024 | 23.90 Mn |
| Sep 30, 2024 | 23.90 Mn |
| Jun 30, 2024 | -4.40 Mn |
| Jun 30, 2024 | -4.40 Mn |
| Mar 31, 2024 | -12.40 Mn |
| Mar 31, 2024 | -12.40 Mn |